
|Slideshows|December 23, 2015
Neuro News Roundup: Stroke Risks & Treatments
Author(s)Mark L. Fuerst
The risks and benefits of intravenous tissue plasminogen activator and endovascular thrombectomy are discussed in the following slides.
Advertisement
 Â
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Dravet Syndrome Medication Stiripentol Effective in Real World Settings Across Various Patient Profiles
2
US Survey Reveals Underuse of Dravet Syndrome–Specific Antiseizure Medications in the Clinic
3
AES Poster Lays Insights Into EEG and MRI Biomarkers of MOGAD-Related Epilepsy
4
AES Presentations Highlight Zorevunersen as Disease-Modifying Treatment for Dravet Syndrome
5


































